PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 187 filers reported holding PDL BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 2.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $29,000 | -80.0% | 10,312 | -80.5% | 0.00% | -100.0% |
| Q4 2017 | $145,000 | -19.4% | 52,800 | -0.4% | 0.00% | 0.0% |
| Q3 2017 | $180,000 | -93.2% | 53,000 | -93.7% | 0.00% | -94.4% |
| Q2 2016 | $2,628,000 | -37.6% | 836,862 | -33.8% | 0.05% | -39.3% |
| Q1 2016 | $4,211,000 | +6002.9% | 1,264,679 | +11610.0% | 0.09% | +8800.0% |
| Q2 2015 | $69,000 | -9.2% | 10,800 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $76,000 | -87.4% | 10,800 | -85.8% | 0.00% | -90.0% |
| Q3 2013 | $605,000 | – | 75,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HAYS ADVISORY LLC | 1,037,600 | $6,672,000 | 0.97% |
| Global X Management CO LLC | 2,435,411 | $15,660,000 | 0.86% |
| Advisors Asset Management, Inc. | 5,373,113 | $34,549,000 | 0.47% |
| Gotham Asset Management, LLC | 7,233,838 | $46,514,000 | 0.39% |
| TFS CAPITAL LLC | 582,438 | $3,745,000 | 0.37% |
| LOMBARDIA CAPITAL PARTNERS LLC | 1,637,611 | $10,530,000 | 0.36% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 95,122 | $611,634,000 | 0.33% |
| FIRST TRUST ADVISORS LP | 17,536,793 | $112,762,000 | 0.29% |
| Arrow Investment Advisors, LLC | 214,595 | $1,380,000 | 0.28% |
| GSA CAPITAL PARTNERS LLP | 954,853 | $6,140,000 | 0.24% |